SLS
NASDAQ HealthcareSELLAS Life Sciences Group, Inc. - Common Stock
Biotechnology
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
๐ Market Data
| Price | $8.33 |
|---|---|
| Volume | 10,153,906 |
| Market Cap | 1.55B |
| Beta | 2.240 |
| RSI (14-Day) | 68.1 |
| 200-Day MA | $3.53 |
| 50-Day MA | $5.73 |
| 52-Week High | $9.51 |
| 52-Week Low | $1.39 |
| Forward P/E | -55.53 |
| Price / Book | 14.07 |
๐ฏ Investment Strategy Scores
SLS scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (91/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ช Falling Knife (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find SLS in your text
Paste any article, transcript, or post โ the tool will extract SLS and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.